Discover TCR mimic antibodies that Target Previously “Undruggable” Intracellular Proteins with Keyway™ TCR
Webinar Overview: Unlock access to intracellular protein targets and maximize TCRm/TCR-based therapeutic antibody discovery with this presentation by Dr. Dongxing Zha that reveals how Alloy’s proprietary Keyway™ TCRm Discovery Platform and expertise can: Overcome challenges to intracellular protein-targeted drug discovery: Learn how the Keyway™ TCRm Discovery Platform identifies TCR mimic (TCRm) antibodies that target intracellular […]
Accelerating Therapeutic Discovery: ATX-Gx™ Human, Transgenic Platform
Webinar Overview Ready to dramatically accelerate your therapeutic antibody discovery pipeline? In this presentation, Dr. John “Lippy” Lippincott shares how our ATX-Gx™ human, transgenic mouse platform can help: Accelerate antibody discovery: Learn how this platform, used by 100’s of biotechs and large pharma, can significantly speed up the identification of therapeutic antibody candidates against diverse […]
High Velocity AI-Enabled and ML-Powered Therapeutic Antibody Discovery
High velocity, AI-enabled and ML-powered therapeutic antibody discovery and optimization Download the poster to see how Al/ML technologies and workflows combined with a proprietary high-throughput screening method accelerate antibody discovery and lead optimization. Download the poster Contact Us AI-enabled and ML-powered antibody discovery for faster and higher quality leads Therapeutic antibody discovery is becoming faster […]
Highly Specific anti-WT1/HLA-A2 TCRm Antibodies
New Data: unlocking the potential of TCRm antibodies Download the poster and explore the discovery of highly specific anti-WT1/HLA-A2 TCR-like antibodies. Download the poster Contact Us Keyway™ TCRm antibody discovery platform is revolutionizing immunotherapy development In a significant study, Alloy Therapeutics researchers identified T Cell Receptor mimic (TCRm) antibodies with exceptional specificity for the Wilms […]
How AI is reshaping antibody discovery and optimization workflows
In silico antibody discovery and optimization: How computational tools are reshaping the workflow AI-enabled and ML-powered methods are enabling faster identification and engineering of high-quality therapeutic antibody leads The field of antibody discovery is experiencing a transformative shift through the integration of cutting-edge artificial intelligence (AI) and machine learning (ML) technologies. Traditional methods of antibody […]
Discovery of highly-specific TCR mimic antibodies to WT1
Navigating high homology: Discovery of TCR mimic antibodies with greater specificity to Wilms tumor 1 antigen The development of TCR mimic (TCRm) antibodies (or TCR-like antibodies) offers a promising new approach for cancer immunotherapy but identifying TCRm antibody candidates with optimal specificity and low off-target effects can be challenging. Here, we look at an antibody […]
Discovering Antibodies in Months
Access the webinar recording Thanks for your interest in our recent antibody discovery webinar, Discovering Antibodies in Months: New Advances in HT-SPR, Single-Cell BCR-Seq and RNA-Seq. Alloy Head of Global Bioanalytics Dr. Lucy Liu presented on our workflow that improve the speed and quality of the antibody discovery process. Please fill out your contact information, and […]
Approaches to Binder Recovery Following Immunization Campaigns in Mouse Models
Harnessing the Potential of Human Lambda Light Chains in Antibody Discovery Campaigns
Targeting GPCRs With DeepImmune™
